Janus kinase inhibitors – a role for the treatment of cutaneous T-cell lymphomas?
Despite increases in prevalence, many cutaneous T-cell lymphoma (CTCL) patients still lack effective and safe therapies for their disease. The most prevalent subtype, mycosis fungoides is usually managed with skin directed treatments in early stages, while advanced stages are often targeted with sys...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2025-08-01
|
| シリーズ: | Oncology Reviews |
| 主題: | |
| オンライン･アクセス: | https://www.frontiersin.org/articles/10.3389/or.2025.1482866/full |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|